The purpose of this study is to validate a predictive model of diabetic retinopathy progression in patients with diabetes mellitus type 2 patients to clinically significant macular edema (CSME) needing treatment either photocoagulation or intravitreal injections (ITV) using non-invasive techniques.
Study Type
OBSERVATIONAL
Enrollment
200
LV Prasad Eye Institute
Hyderabad, Andhra Pradesh, India
AIBILI- Association for Biomedical Research and Inovation on Light and Image.
Coimbra, Portugal
CSME needing treatment either photocoagulation or ITV.
Time frame: Months 0, 6, 12 and 24.
Best corrected visual acuity.
Time frame: Months 0, 6, 12 and 24.
Vision loss of at least 2 lines documented in ETDRS charts
Time frame: Months 0, 6, 12 and 24.
Central retinal thickness
Time frame: Months 0, 6, 12 and 24.
Microaneurysm(MA) activity (number of MA, MA formation and MA disappearance rates and MA turnover)
Time frame: Months 0, 6, 12 and 24.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.